Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- CZK 114.27T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | CZK 107.6B | CZK 306.72 | 0.58% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | CZK 200.2B | CZK 2,107.62 | 1.16% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | CZK 148.7B | CZK 2,193.13 | 2.52% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | CZK 118.5B | CZK 2,808.79 | 0.46% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | CZK 89.6B | CZK 654.53 | 0.31% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | CZK 168.1B | CZK 2,139.84 | 1.30% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | CZK 109.2B | CZK 1,938.71 | 0.36% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | CZK 213.1B | CZK 1,409.76 | 1.22% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | CZK 524.4B | CZK 457.41 | 0.71% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | CZK 625.3B | CZK 863.03 | 0.38% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | CZK 102.7B | CZK 938.04 | 0.46% up | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | CZK 165.7B | CZK 475.45 | 1.36% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | CZK 879.1B | CZK 1,528.94 | 0.23% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | CZK 1.11T | CZK 950.79 | 0.47% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | CZK 711.2B | CZK 1,153.37 | 0.06% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | CZK 189.5B | CZK 6,779.16 | 0.06% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | CZK 172.4B | CZK 1,025.99 | 1.64% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | CZK 1.53T | CZK 478.07 | 0.55% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | CZK 7.7T | CZK 3,122.95 | 1.95% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | CZK 182.6B | CZK 2,797.35 | 1.03% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | CZK 108.7B | CZK 1,132.27 | 0.23% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | CZK 132.1B | CZK 6,602.37 | 1.18% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | CZK 14.88T | CZK 6,182.82 | 0.16% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | CZK 342.6B | CZK 5,336.73 | 0.18% down | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | CZK 2.22T | CZK 21,429.76 | 0.74% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | CZK 28.03T | CZK 31,467.57 | 0.10% up | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | CZK 2.77T | CZK 1,353.26 | 0.73% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | CZK 142.3B | CZK 3,502.96 | 0.00% | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | CZK 132.7B | CZK 2,032.88 | 0.46% down | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | CZK 394.9B | CZK 6,019.80 | 0.06% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | CZK 3.01T | CZK 11,891.23 | 0.22% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | CZK 11.45T | CZK 6,477.10 | 0.42% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | CZK 6.61T | CZK 3,499.41 | 1.01% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | CZK 552.6B | CZK 12,976.30 | 0.03% up | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | CZK 293.2B | CZK 586.57 | 2.17% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | CZK 333.2B | CZK 1,710.61 | 0.29% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | CZK 1.04T | CZK 9,098.55 | 0.87% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | CZK 3.6T | CZK 632.21 | 0.02% up | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | CZK 178.5B | CZK 2,574.36 | 0.60% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | CZK 253.7B | CZK 1,309.95 | 0.80% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | CZK 135.3B | CZK 956.92 | 0.22% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | CZK 2.19T | CZK 1,093.18 | 0.01% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | CZK 276.6B | CZK 331.82 | 0.95% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | CZK 6.23T | CZK 4,017.23 | 0.74% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | CZK 130.4B | CZK 191.67 | 0.00% | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | CZK 2.54T | CZK 1,056.09 | 0.04% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | CZK 159.6B | CZK 3,034.33 | 0.49% up | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | CZK 171.7B | CZK 1,569.25 | 0.83% up | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | CZK 3.95T | CZK 896.28 | 0.86% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | CZK 4.03T | CZK 2,325.50 | 0.05% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | CZK 111.7B | CZK 1,337.60 | 0.22% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | CZK 161.1B | CZK 1,156.14 | 0.78% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | CZK 109.3B | CZK 628.32 | 1.58% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | CZK 216.9B | CZK 9,338.86 | 0.36% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | CZK 161.7B | CZK 1,846.98 | 1.29% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | CZK 758.7B | CZK 1,867.19 | 0.71% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | CZK 187.5B | CZK 234.43 | 1.08% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | CZK 594.8B | CZK 2,711.40 | 0.18% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | CZK 72.3B | CZK 372.91 | 4.22% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | CZK 101.7B | CZK 610.78 | 2.00% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | CZK 465.3B | CZK 3,473.87 | 0.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2100 CZK).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of CZK 114.27T as of 18 Nov 2026, 14:39 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.